Driving innovation in pharmaDriving innovation in pharma

In an insightful interview, Mansoor Meenai, Interim General Manager for META at ACINO, shares how ACINO’s state-of-the-art manufacturing facility aligns with the UAE's Vision 2030, emphasising industrial diversification and self-sufficiency. He discusses the facility’s unique features, sustainability initiatives, and the company's dedication to employee well-being, while also providing a glimpse into ACINO’s future plans for growth and innovation in the region. Excerpts:

How does Acino’s manufacturing site align with UAE's manufacturing strategy?

Acino's manufacturing facility aligns seamlessly with the UAE's Vision 2030 and industrial strategy with a focus on industrial diversification and self-sufficiency in pharmaceuticals, among other industries. By integrating advanced EU, GMP and GCC-certified production capabilities locally, we’re contributing to strengthening the UAE’s position to  become a global pharmaceutical hub. Our commitment to quality and innovation bolsters the nation's healthcare infrastructure, driving to economic growth and reduced dependency on pharmaceutical imports. Our 1,300-sqm manufacturing site has an annual production capacity of over 250 million tablets and 87 million capsules.

Mansoor Meenai

How does this facility distinguish itself from other players?

We seamless combine our international expertise with local engagement. Our facility stands out for its state-of-the-art technology, adherence to the highest international standards, and strategic integration with Pharmax Pharmaceuticals. The EU, GMP and GCC certifications reflect our commitment to quality and operational excellence. Additionally, our end-to-end solutions—from regulatory registration to commercialisation—ensure efficiency and effectiveness, distinguishing Acino as a trusted partner in the region.

How important is sustainability for pharma companies, and what efforts does Acino make in this area?

Sustainability is crucial for the pharma sector, impacting both environmental and societal well-being. At Acino, we prioritise sustainable practices such as using LPG for heating processes and implementing robust recycling and energy conservation programmes to monitor and control usage. These efforts not only reduce our carbon footprint but also ensure long-term operational resilience and alignment with global sustainability goals.

How are you also ensuring that the employees' mental health is well managed, considering the job can be taxing for many?

We prioritise our employees' mental health. We recently introduced a new wellbeing programme and we provide access to regular mental health workshops, as well as professional counselling services. We also foster a supportive work environment that encourages open communication, work-life balance, and stress management practices to ensure our employees' well-being is well managed. Acino has also transformed into a modern workplace over the years with hybrid and remote working policies to ensure our workforce can strike a better work-life balance while remaining productive.

What are your plans for the upcoming years?

We look forward to expanding our manufacturing capabilities, investing in advanced technologies, and enhancing our product portfolio to meet the region's evolving needs. We aim to strengthen our strategic partnerships, drive innovation, and contribute to the UAE’s vision of becoming a global pharmaceutical leader, ensuring sustainable growth and operational excellence.